|
Market Closed -
Nasdaq
05:00:00 20/11/2026 HKT
|
5-day change | 1st Jan Change | ||
| 104.91 USD | -4.42% |
|
-3.06% | +2.47% |
| 11-17 | Mizuho Initiates T. Rowe Price at Underperform With $94 Price Target | MT |
| 11-17 | Galvanize Therapeutics, Inc. announced that it has received $130 million in funding from a group of investors | CI |
Company Valuation: T. Rowe Price Group, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 45,070 | 24,371 | 24,066 | 25,124 | 22,343 | 23,415 | - | - |
| Change | - | -45.93% | -1.25% | 4.4% | -11.07% | 4.8% | - | - |
| Enterprise Value (EV) 1 | 43,546 | 22,615 | 21,999 | 22,474 | 18,965 | 19,129 | 18,518 | 17,728 |
| Change | - | -48.07% | -2.73% | 2.16% | -15.61% | 0.86% | -3.19% | -4.27% |
| P/E | 15x | 16.3x | 13.9x | 12.4x | 11.1x | 10.4x | 10.1x | 10.2x |
| PBR | 5x | 2.77x | 2.54x | 2.44x | 2.06x | 2.29x | 2.09x | 2x |
| PEG | - | -0.3x | 0.9x | 0.7x | 11.29x | 0.7x | 3.91x | -9.11x |
| Capitalization / Revenue | 5.87x | 3.76x | 3.73x | 3.54x | 3.02x | 3.02x | 2.99x | 3x |
| EV / Revenue | 5.68x | 3.49x | 3.41x | 3.17x | 2.57x | 2.47x | 2.36x | 2.27x |
| EV / EBITDA | 11.1x | 8.3x | 8.74x | 7.64x | 6.07x | 6.14x | 5.76x | 5.95x |
| EV / EBIT | 11.7x | 9.04x | 9.72x | 8.37x | 6.97x | 6.86x | 6.84x | 6.81x |
| EV / FCF | 13.6x | - | 24.1x | 17.8x | - | 9.05x | 7.84x | 8.84x |
| FCF Yield | 7.38% | - | 4.14% | 5.62% | - | 11% | 12.8% | 11.3% |
| Dividend per Share 2 | 4.32 | 4.8 | 4.88 | 4.96 | 5.08 | 5.184 | 5.161 | 5.05 |
| Rate of return | 2.2% | 4.4% | 4.53% | 4.39% | 4.96% | 4.72% | 4.7% | 4.6% |
| EPS 2 | 13.12 | 6.7 | 7.76 | 9.15 | 9.24 | 10.59 | 10.87 | 10.74 |
| Distribution rate | 32.9% | 71.6% | 62.9% | 54.2% | 55% | 48.9% | 47.5% | 47% |
| Net sales 1 | 7,672 | 6,488 | 6,460 | 7,094 | 7,387 | 7,753 | 7,832 | 7,803 |
| EBITDA 1 | 3,915 | 2,726 | 2,518 | 2,940 | 3,127 | 3,115 | 3,216 | 2,981 |
| EBIT 1 | 3,710 | 2,500 | 2,263 | 2,686 | 2,721 | 2,787 | 2,709 | 2,603 |
| Net income 1 | 3,002 | 1,522 | 1,744 | 2,044 | 2,036 | 2,305 | 2,352 | 2,142 |
| Net Debt 1 | -1,523 | -1,756 | -2,067 | -2,650 | -3,378 | -4,286 | -4,896 | -5,687 |
| Reference price 2 | 196.64 | 109.06 | 107.69 | 113.09 | 102.38 | 109.76 | 109.76 | 109.76 |
| Nbr of stocks (in thousands) | 229,198 | 223,465 | 223,470 | 222,159 | 218,237 | 213,326 | - | - |
| Announcement Date | 27/1/22 | 26/1/23 | 8/2/24 | 5/2/25 | 4/2/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 10.36x | 2.47x | 6.14x | 4.72% | 23.41B | ||
| 22.21x | 6.05x | 13.07x | 1.96% | 181B | ||
| 13.57x | 3.26x | - | 2.64% | 139B | ||
| 15.83x | 7.25x | - | 1.56% | 99.45B | ||
| 19.43x | 6.94x | 12.36x | 4.39% | 92.54B | ||
| 18.71x | 11.18x | 17.27x | 0.83% | 83.58B | ||
| 20.47x | 12.82x | 22.27x | 3.98% | 80.45B | ||
| 12.28x | 4.74x | - | 2.12% | 44.93B | ||
| 10.83x | 1.6x | 4.98x | 1.34% | 43.53B | ||
| Average | 15.96x | 6.26x | 12.68x | 2.62% | 87B | |
| Weighted average by Cap. | 17.46x | 6.62x | 14.08x | 2.46% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- TROW Stock
- Valuation T. Rowe Price Group, Inc.
Select your edition
All financial news and data tailored to specific country editions
















